Plain-English translation of NCT06556251 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a digital platform called PIPPEP that is designed to help young people with early signs of psychosis stay connected to their treatment and care. The platform offers digital support alongside the regular care you'd normally receive at an early intervention psychosis programme. Researchers want to see if using this app alongside standard treatment helps people stick with their care and feel better.
Many young people with early psychosis stop coming to appointments or drop out of treatment — sometimes up to half of all patients. This study exists because researchers believe that offering a user-friendly digital tool might help young people stay engaged, reduce the stigma they feel about getting mental health care, and make it easier to monitor how they're doing between appointments.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will either receive the digital platform PIPPEP in addition to your regular early intervention treatment, or you will continue with standard treatment alone (this is decided randomly). If you receive the platform, you would use the app on your phone or device to track your symptoms, connect with your care team, and access supportive tools. You would continue attending your regular appointments and treatments as usual. The study involves 128 young people total and will track how well the platform helps with engagement and recovery over time.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
Spain